FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:1678-1680 November 28, 1996 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

For nearly three years we have known that zidovudine is efficacious in preventing transmission of the human immunodeficiency virus (HIV) from mother to infant.¹ A randomized, placebo-controlled trial, AIDS Clinical Trials Group Protocol 076, established a new standard of care for pregnant women with HIV type 1 infection. This issue of the Journal includes the report by Sperling et al. of an analysis of Protocol 076 after 402 mother–infant pairs were followed for 18 months.² During that period, 15 infants in the zidovudine group (7.6 percent) and 46 infants in the placebo group (22.6 percent) were found to be infected. . . . [Full Text of this Article]

References

Related Letters:

Treatment of Burns
Schimmer M., Bermúdez R. M., Cabrera C. A., Monafo W. W.
Extract | Full Text  
N Engl J Med 1997; 336:1392-1393, May 8, 1997. Correspondence

This article has been cited by other articles:

• Minkoff, H., Bauer, T. A. (1997). Mother-to-Infant Transmission of HIV. NEJM 336: 1392-1392 [Full Text]  
• (1997). Maternal Viral Load and Perinatal Transmission. AIDS Clin Care 1997: 2-2 [Full Text]